The Role of Preoperative Oral Immunonutrition in Major Vascular Surgery
This study has been completed.
Sponsor:
Centre Hospitalier Universitaire de Nice
Collaborator:
Novartis
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Nice
ClinicalTrials.gov Identifier:
NCT00559520
First received: November 14, 2007
Last updated: December 8, 2011
Last verified: December 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The role of preoperative oral immunonutrition in major vascular surgery.
The mean purpose of this study was to determine the prevalence of post-operative infection complications after major vascular surgery in group of patients with preoperative oral immunonutrition.
This group was compared to a control group.
Secondary purpose was to evaluate the effect of preoperative oral immunonutrition on postoperative mortality (30 days), the medium length of stay in the hospital and the cost of treatment in the two groups
| Condition | Intervention | Phase |
|---|---|---|
|
Undernutrition |
Dietary Supplement: Impact Dietary Supplement: Oral Impact |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Factorial Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Screening |
| Official Title: | The Role of Preoperative Oral Immunonutrition in Major Vascular Surgery |
Resource links provided by NLM:
Further study details as provided by Centre Hospitalier Universitaire de Nice:
Primary Outcome Measures:
- Weight [ Time Frame: before surgery, five days and thirty days after surgery ] [ Designated as safety issue: No ]
- Arisen of an infectious complication [ Time Frame: during the period of 30 days following the surgery ] [ Designated as safety issue: No ]
- Arisen of non infectious complication [ Time Frame: during the period of 30 days following the surgery ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Primary and secondary permeability [ Time Frame: at 5 and 30 days after surgery ] [ Designated as safety issue: No ]
- Pain [ Time Frame: at 5 and 30 days after surgery ] [ Designated as safety issue: No ]
- Healing [ Time Frame: at 5 and 30 days after surgery ] [ Designated as safety issue: No ]
| Enrollment: | 250 |
| Study Start Date: | February 2002 |
| Study Completion Date: | December 2011 |
| Primary Completion Date: | November 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Impact
patient receiving 3 drinks "Impact" a day during 5 days before surgery
|
Dietary Supplement: Impact
Patient receiving 3 drinks "Impact" a day during 5 days before surgery
|
|
Experimental: Oral Impact
Patient receiving 3 drinks "Oral Impact" a day during 5 days before surgery
|
Dietary Supplement: Oral Impact
Patient receiving 3 drinks "Oral Impact" a day during 5 days before surgery
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Intervention planned since at least 5 days before surgery
- Duration of hospitalization of at least 5 days
Exclusion Criteria:
- Pregnant or lactating woman
- Patient with severe renal insufficiency
- Patient under 18 years old
- Patient infected with HIV,hépatitis B or C
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00559520
Locations
| France | |
| CHU de NICE, Department of Vascular Surgery | |
| Nice, France, 06000 | |
Sponsors and Collaborators
Centre Hospitalier Universitaire de Nice
Novartis
Investigators
| Principal Investigator: | Michel BATT, Professeur | Department of Vascular Surgery, CHU de NICE |
More Information
Publications:
| Responsible Party: | Centre Hospitalier Universitaire de Nice |
| ClinicalTrials.gov Identifier: | NCT00559520 History of Changes |
| Other Study ID Numbers: | PHRC 2004 |
| Study First Received: | November 14, 2007 |
| Last Updated: | December 8, 2011 |
| Health Authority: | France: Direction Générale de la Santé France: Institutional Ethical Committee |
Keywords provided by Centre Hospitalier Universitaire de Nice:
|
Patients Suffering Undernutrition |
Requiring Vascular Surgery |
Additional relevant MeSH terms:
|
Malnutrition Nutrition Disorders |
ClinicalTrials.gov processed this record on May 23, 2013